Your browser doesn't support javascript.
loading
Intratumoral Heterogeneity in a Patient With Metastatic Thymic Carcinoma on 18F-FDG, 68Ga-DOTATATE, and 68Ga-FAPI04 PET/CT.
Isik, Emine Göknur; Kuyumcu, Serkan; Ozkan, Zeynep Gözde; Has Simsek, Duygu; Sanli, Yasemin.
Affiliation
  • Isik EG; From the Department of Nuclear Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Clin Nucl Med ; 47(1): e79-e80, 2022 Jan 01.
Article in En | MEDLINE | ID: mdl-34392280
ABSTRACT
ABSTRACT Herein, we present a 72-year-old woman with metastatic thymic carcinoma, referred for salvage peptide receptor radionuclide therapy with 177Lu-DOTATATE after completing all treatment options according to current clinical practice and guidelines. However, the patient was not eligible for 177Lu-DOTATATE peptide receptor radionuclide therapy and underwent 68Ga-FAPI04 PET/CT to assess the potential for a FAP-targeted therapy.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Organometallic Compounds / Thymoma / Thymus Neoplasms Type of study: Guideline Limits: Aged / Female / Humans Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Organometallic Compounds / Thymoma / Thymus Neoplasms Type of study: Guideline Limits: Aged / Female / Humans Language: En Year: 2022 Type: Article